Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review.

MLA

Shen, Haixiang, et al. “Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review.” OncoTargets & Therapy, vol. 12, Dec. 2019, pp. 11549–53. EBSCOhost, https://doi.org/10.2147/OTT.S233868.

APA

Shen, H., Wang, Z., Feng, M., Liu, J., Li, J., Wang, X., & Xu, X. (2019). Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review. OncoTargets & Therapy, 12, 11549–11553. https://doi.org/10.2147/OTT.S233868

Chicago

Shen, Haixiang, Zhize Wang, Meibao Feng, Jin Liu, Jiangfeng Li, Xiao Wang, and Xin Xu. 2019. “Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review.” OncoTargets & Therapy 12 (December): 11549–53. doi:10.2147/OTT.S233868.